AbCellera Biologics
Discovers antibodies for partners and advances its own clinical candidates.
$11.37
After-hours close+0.03 (+0.24%)
At close$11.35(−8.51%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.18 | — | — |
| Aug 2026 | −$0.16 | −$0.18 | −9.8% |
| May 2026 | −$0.22 | −$0.14 | +36.4% |
| Feb 2026 | −$0.18 | −$0.03 | +83.3% |
| Nov 2025 | −$0.17 | −$0.19 | −11.8% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.18 | — | — | $5.3M | — | — |
| Aug 5, 2026 | −$0.16 | −$0.18 | −9.8% | $7.8M | $4.1M | −48.4% |
| May 11, 2026 | −$0.22 | −$0.14 | +36.4% | $5.4M | $8.3M | +53.6% |
| Feb 24, 2026 | −$0.18 | −$0.03 | +83.3% | $6.7M | $44.9M | +572.9% |
| Nov 6, 2025 | −$0.17 | −$0.19 | −11.8% | $6.3M | $9.0M | +41.9% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 20, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Feb 21, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 29, 2021 | ||||||
| Dec 14, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||